SANUWAVE Health, Inc.
Income Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $44.1M | $32.6M | $20.4M | $16.7M | $13.0M | $4.1M | $1.5M | $1.9M |
| Cost of Revenue | $10.1M | $8.1M | $6.0M | $4.3M | $5.0M | $1.2M | $538.9K | $693.7K |
| Gross Profit | $34.0M | $24.6M | $14.4M | $12.4M | $8.0M | $2.9M | $489.8K | $1.2M |
| Gross Margin | 77.1% | 75.2% | 70.4% | 74.1% | 61.7% | 71.4% | 32.0% | 62.5% |
| Operating Expenses | ||||||||
| Research & Development | $1.4M | $673.0K | $579.0K | $567.0K | $1.1M | $1.2M | $1.2M | $981.7K |
| SG&A Expense | $19.4M | $12.9M | $8.7M | $12.6M | $11.7M | $13.7M | $6.4M | $6.8M |
| Operating Income | $4.9M | $3.8M | $-540.0K | $-9.0M | $-14.1M | $-25.2M | $-8.8M | $-7.2M |
| Operating Margin | 11.2% | 11.8% | -2.6% | -53.5% | -108.7% | -621.1% | -575.3% | -388.1% |
| Interest Expense | — | $12.6M | — | $12.8M | $6.9M | $2.0M | $1.8M | $4.5M |
| Pretax Income | $11.9M | $-33.1M | — | — | — | — | — | — |
| Income Tax Expense | $86.0K | $27.0K | $4.0K | $2.0K | $28.0K | $0 | $0 | $0 |
| Net Income | $11.8M | $-33.1M | $-25.8M | $-10.3M | $-27.3M | $-30.9M | $-10.4M | $-11.6M |
| Net Margin | 26.8% | -101.4% | -126.5% | -61.5% | -209.5% | -762.6% | -682.3% | -628.7% |
| EPS (Basic) | $1.38 | $-3.71 | $-6.10 | $-0.01 | $-0.03 | $-0.04 | $-0.03 | $-0.04 |
| EPS (Diluted) | $0.41 | $-3.71 | $-6.10 | $-0.01 | $-0.03 | $-0.04 | $-0.03 | $-0.04 |
| Shares Outstanding (Basic) | 8.6M | 8.9M | 1.59B | 1.10B | 1.04B | 756.3M | 407.2M | 311.3M |
| Shares Outstanding (Diluted) | 9.1M | 8.9M | 1.59B | 1.10B | 1.04B | 756.3M | 407.2M | 311.3M |
| Dividends Per Share | — | — | — | — | — | — | — | — |